The 27 references in paper O. Demidova A., E. Shikh V., О. Демидова А., Е. Ших В. (2018) “АНАЛЬГЕТИЧЕСКИЙ ПОТЕНЦИАЛ АГОНИСТОВ ПУРИНОВЫХ РЕЦЕПТОРОВ И ВИТАМИНОВ ГРУППЫ B В ЛЕЧЕНИИ ДИАБЕТИЧЕСКОЙ ПОЛИНЕЙРОПАТИИ // ANALGESIC POTENTIAL OF PURINE RECEPTOR AGONISTS AND B VITAMINS IN THE TREATMENT OF DIABETIC POLYNEUROPATHY” / spz:neicon:vedomostincesmp:y:2018:i:1:p:17-22

1
Букатина ТМ, Казаков АС, Каперко ДА, Романова ТВ. Канаглифлозин и риск ампутаций у пациентов с сахарным диабетом 2 типа. Безопасность и риск фармакотерапии 2017; 5(3): 100–3. [Bukatina TM, Kazakov AS, Kaperko DA, Romanova TV. Canagliflozin and risk of amputation in patients with type 2 diabetes. Safety and Risk of Pharmacotherapy 2017; 5(3): 100–3 (In Russ.)]
(check this in PDF content)
2
Галиева ОР, Джанашия ПХ, Мирина ЕЮ. Лечение диабетической нейропатии. Международный неврологический журнал 2008; (1): 77–81. [Galieva OR, Dzhanashiya PH, Mirina EYu. Treatment of diabetic neuropathy. International Journal of Neurology 2008; (1): 77–81 (In Russ.)]
(check this in PDF content)
3
Грацианская АН. Лечение диабетической полинейропатии. Трудный пациент 2009; 7(8–9): 47–50. [Gratsianskaya AN. The treatment of diabetic polyneuropathy. Difficult Patient 2009; 7(8–9): 47–50 (In Russ.)]
(check this in PDF content)
4
Javed S, Petropoulos IN, Alam U, Malik RA. Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis. 2015; 6(1): 15–28.
(check this in PDF content)
5
Burnstock G. Co-transmission. Arch Int Pharmacodyn Ther. 1990; (304): 7–33.
(check this in PDF content)
6
Pelleg A, Belhassen B, Ilia R, Laniado S. Comparative electrophysiologic effects of adenosine triphosphate and adenosine in the canine heart: influence of atropine, propranolol, vagotomy, dipyridamole and aminophylline. Am J Cardiol. 1985; 55(5): 571–6.
(check this in PDF content)
7
Robinson DA, Wang P, Chaudry JH. Administration of ATP-MgCl2 after trauma haemorrhage and resuscitation restores the depressed cardiac performance. J Surg Res. 1997; 69(1): 159–65.
(check this in PDF content)
8
Li X, Eisenach JC. Adenosine reduces glutamate release in rat spinal synaptosomes. Anesthesiology 2005; 103(5): 1060–5.
(check this in PDF content)
9
Карелов АЕ, Захаров ДА, Лебединский КМ, Семенов ДА. Новые технологии в анестезиологии: пуриновая анальгезия. Вестник Санкт-Петербургского университета 2008; (S1): 77–82. [Karelov AE, Zakharov DA, Lebedinsky KM, Semenov DA. New technologies in anesthesiology: purine analgesia. Vestnik of Saint Petersburg University 2008; (S1): 77–82 (In Russ.)]
(check this in PDF content)
10
Robinson DA, Wang P, Chaudry JH. Administration of ATP-MgCl2 after trauma haemorrhage and resuscitation restores the depressed cardiac performance. J Surg Res. 1997; 69(1): 159–65.
(check this in PDF content)
11
Козловский ВА, Шмалий ВИ. АТФ как мессенджер и мессенджер как мишень терапевтического воздействия. Лiки Украiни 2008; (3): 48–52. [Kozlovsky VA, Shmaliy VI. ATP as an instant messenger and a messenger as a target of therapeutic effects. Medicines of Ukraine 2008; (3): 48–52 (In Russ.)]
(check this in PDF content)
12
Карелов АЕ, Лебединский КМ. Анальгетические адъюванты или альтернативные анальгетики? Вестник анестезиологии и реаниматологии 2013; 10(6): 72–80. [Karelov AE, Lebedinsky KM. Analgesic adjuvants or alternative analgesic. Messenger of Anesthesiology and Resuscitation 2013; 10(6): 72–80 (In Russ.)]
(check this in PDF content)
13
Handa T, Fukuda K, Hayashida M, Koukita Y, Ichinohe T, Kaneko Y. Effects of intravenous adenosine 5’-triphosphate on intraoperative hemodynamics and postoperative pain in patients undergoing major orofacial surgery: a double-blind placebo-controlled study. J Anesth. 2009; 23(3): 315–22.
(check this in PDF content)
14
Segerdahl M, Karelov A. Experimentally induced ischaemic pain in healthy humans is attenuated by the adenosine receptor antagonist theophylline. Acta Physiol Scand. 2004; 180(3): 301–6.
(check this in PDF content)
15
Карелов АЕ, Алеева РШ, Горохов КА, Патлай ИВ. Эффекты активации и блокады пуриновых рецепторов при сильном ноцицептивном раздражении у бодрствующих добровольцев. Эфферентная терапия 2010; 16(3): 86–90. [Karelov AE, Aleeva RSh, Gorokhov KA, Patlay IV. Effects of activation and blockade of the purine receptors with strony nociceptive stimulation in awake volunteers. Efferent Therapy 2010; 16(3): 86–90 (In Russ.)]
(check this in PDF content)
16
Belfrage M, Sollevi A, Segerdahl M, Sjolund KF, Hansson P. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg. 1995; 81(4): 713–7.
(check this in PDF content)
17
Borsook D, Kussman BD, George E, Becerra LR, Burke DW. Surgically induced neuropathic pain: understanding the perioperative process. Ann Surg. 2013; 257(3): 403–12.
(check this in PDF content)
18
Парцева НО, Данилова АВ, Пастарус ЛН. Стратегия комплексного патогенетического лечения диабетической нейропатии. Международный эндокринологический журнал 2012; (7): 33–5. [Partseva NO, Danilova AV, Pastarus LN. The strategy of complex pathogenetic treatment of diabetic neuropathy. International Journal of Endocrinology 2012; (7): 33–5 (In Russ.)]
(check this in PDF content)
19
Wang ZB, Gan Q, Rupert RL, Zeng YM, Song XJ. Thiamine, pyridoxine, cyanocobalamin and their combinatuin inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron loss. Pain
(check this in PDF content)
20
5; 114(1–2): 266–77. 20. Тлегенов АЕ. Эффективность лечения диабетической полинейропатии витаминами группы В. Медицина 2013; (10): 40–2. [Tlegenov AE. The effectiveness of treatment of diabetic polyneuropathy in vitamin B. Medicine 2013; (10): 40–2 (In Russ.)]
(check this in PDF content)
21
Умерова АР, Дорфман ИП, Орлова ЕА. Современные подходы к лечению диабетической полинейропатии. Русский медицинский журнал 2015; (26): 1538–42. [Umerova AR, Dorfman IP, Orlova EA. Modern approaches to treatment of diabetic polyneuropathy. Russian Medical Journal 2015; (26): 1538–42 (In Russ.)]
(check this in PDF content)
22
Caram-Salas NL, Reyes-Garcia G, Medina-Santillan R, Granados-Soto V. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone. Pharmacology 2006; 77(2): 53–62.
(check this in PDF content)
23
Mixcoatl-Zecuatl T, Quinonez-Bastidas GN, Caram-Salas NL, Ambriz-Tututi M, Araiza-Saldana CI, Rocha-Gonzalez HI et al. Synergistic antiallodinic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats. Methods Find Exp Clin Pharmacol. 2008; 30(6): 431–41.
(check this in PDF content)
24
Granados-Soto V, Sanchez-Ramirez G, La Torre MR, Caram-Salas NL, Medina-Santillan R, Reyes-Garcia G. Effect of diclofenac on the antiallodinic activity of vitamin B12 in a neuropathic pain model in the rat. Proc West Pharmacol Soc. 2004; 47: 92–4.
(check this in PDF content)
25
Hung KL, Wang CC, Huang CY, Wang SJ. Cyanocobalamin, vitamin B12, depresses glutamate release through inhibition of voltagedependent Ca2+ influx in rat cerebrocortical nerve terminals. Eur J Pharmacol. 2009; 602(2–3): 230–7.
(check this in PDF content)
26
Строков ИА, Ахмеджанова ЛТ, Солоха ОА. Эффективность витаминов группы В при лечении болевых синдромов. Русский медицинский журнал 2010; (16): 1014–7. [Strokov IA, Akhmedzhanova LT, Solokha OA. Efficacy of B vitamins in the treatment of pain syndromes. Russian Medical Journal 2010; (16): 1014–7 (In Russ.)]
(check this in PDF content)
27
Монтеро Дж, Данилов АБ. Роль нуклеотидов в лечении периферических нейропатий: обзор. Manage Pain 2015; (4): 33–8. [Montero J, Danilov AB. The role of nucleotides in the treatment of peripheral neuropathy. Manage Pain 2015; (4): 33–8 (In Russ.)] ОБ АВТОРАХ
(check this in PDF content)